Utilization of smoking-cessation pharmacotherapy among chronic obstructive pulmonary disease (COPD) and lung cancer patients

References

• Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance – United States, 1971–2000. Respir Care 2002;47:1184-99
   PubMedGoogle Scholar
• Heron M. Deaths: leading causes for 2008. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2012;60:1-94
   Google Scholar
• The 2004 United States Surgeon General's Report: The health consequences of smoking. NSW Public Health Bulletin 2004;15:107
   Google Scholar
• Koshiol J, Rotunno M, Consonni D, et al. Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case–control study. PLoS One 2009;4:e7380
   PubMed Web of Science ®Google Scholar
• Brown DW, Croft JB, Greenlund KJ, et al. Trends in hospitalization with chronic obstructive pulmonary disease – United States, 1990–2005. COPD 2010;7:59-62
   PubMedGoogle Scholar
• Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569
   PubMed Web of Science ®Google Scholar
• Yohannes AM. Lung cancer in patients with chronic obstructive pulmonary disease is a double blow. Expert Rev Respir Med 2012;6:3-6
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-9
   PubMed Web of Science ®Google Scholar
• Wu J, Sin DD. Improved patient outcome with smoking cessation: when is it too late? Int J Chron Obstruct Pulmon Dis 2011;6:259-67
   PubMed Web of Science ®Google Scholar
• Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010;78:289-301
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Criti Care Med 2013;187:347-65
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46
   PubMed Web of Science ®Google Scholar
• Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004;4:CD000031
   Google Scholar
• Cummings KM, Hyland A. Impact of nicotine replacement therapy on smoking behavior. Annu Rev Publ Health 2005;26:583-99
   PubMed Web of Science ®Google Scholar
• Cox LS, Africano NL, Tercyak KP, et al. Nicotine dependence treatment for patients with cancer. Cancer 2003;98:632-44
   PubMed Web of Science ®Google Scholar
• Jimenez-Ruiz CA, Riesco Miranda JA, Altet Gomez N, et al. Treatment of smoking in smokers with chronic obstructive pulmonary disease. Archivos de Bronconeumologia 2013;49:354-63
   PubMed Web of Science ®Google Scholar
• Vaidya V, Partha G, Howe J. Utilization of preventive care services and their effect on cardiovascular outcomes in the United States. Risk Manag Healthc Pol 2011;4:1-7
   PubMedGoogle Scholar
• Conner NE. Predictive factors of hospice use among Blacks: applying Andersen's Behavioral Model. Am J Hospice Palliative Care 2012;29:368-74
   PubMed Web of Science ®Google Scholar
• Moczygemba LR, Barner JC, Lawson KA, et al. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Am J Geriatr Pharmacother 2011;9:328-38
   PubMed Web of Science ®Google Scholar
• Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Counsel 2011;83:382-90
   PubMed Web of Science ®Google Scholar
• Almagro P, Castro A. Helping COPD patients change health behavior in order to improve their quality of life. Int J COPD 2013;8:335-45
   Google Scholar
• Jyrkkio S, Bostrom P, Minn H. [Smoking and cancer – what are the benefits of cessation?]. Duodecim; laaketieteellinen aikakauskirja 2012;128:1081-7
   PubMedGoogle Scholar
• Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368:351-64
   PubMed Web of Science ®Google Scholar
• Laniado-Laborin R. Smoking cessation intervention: an evidence-based approach. Postgrad Med 2010;122:74-82
   PubMed Web of Science ®Google Scholar
• Patel DR, Feucht C, Reid L, et al. Pharmacologic agents for smoking cessation: a clinical review. Clinical Pharmacol Advances Applications 2010;2:17-29
   PubMedGoogle Scholar
• Hopenhayn C, Christian WJ, Christian A, et al. Factors associated with smoking abstinence after diagnosis of early stage lung cancer. Lung Canc 2013;80:55-61
   PubMed Web of Science ®Google Scholar
• Cooley ME, Sarna L, Kotlerman J, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Canc 2009;66:218-25
   PubMed Web of Science ®Google Scholar
• Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer 2012;118:3153-64
   PubMed Web of Science ®Google Scholar
• Thabane M, Group CW. Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ontario Health Tech Assess 2012;12:1-50
   Google Scholar
• Tilea L, Postolache P, Lica F, et al. Ethics and smoking cessation: should the medical treatment be a freewill choice or a mandatory issue for hospitalized COPD patients? Chest 2012;142:1089A
   Google Scholar
• Waidmann TA, Rajan S. Race and ethnic disparities in health care access and utilization: an examination of state variation. Med Care Res Rev 2000;57(Suppl 1):55-84
   PubMed Web of Science ®Google Scholar
• Vaidya V, Holiday-Goodman M, Pinto S. Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma. J Asthma Allergy 2010;3:101-6
   PubMedGoogle Scholar
• Vaidya V, Peeters MJ, Partha G, et al. Evaluating the association between type of prescription drug plan and asthma patients' use of controller medications. J Pharmaceut Health Serv Res 2012;3:65-9
   Google Scholar
• Kandel DB, Kiros G-E, Schaffran C, et al. Racial/ethnic differences in cigarette smoking initiation and progression to daily smoking: a multilevel analysis. Am J Publ Health 2004;94:128-35
   PubMed Web of Science ®Google Scholar
• Covey LS, Botello-Harbaum M, Glassman AH, et al. Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethn Dis 2008;18:59-64
   PubMed Web of Science ®Google Scholar
• Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville MD, 2010. Available at: http://www.cdc.gov/nchs/data/hus/hus09.pdf
   Google Scholar
• Fiore MC, Goplerud E, Schroeder SA. The Joint Commission's New Tobacco-Cessation Measures – Will Hospitals Do the Right Thing? N Engl J Med 2012;366:1172-4
   PubMed Web of Science ®Google Scholar
• Buck DJ, Richmond RL, Mendelsohn CP. Cost-effectiveness analysis of a family physician delivered smoking cessation program. Prev Med 2000;31:641-8
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services. Available at: http:///www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms [Last accessed 5 September 2013]
   Google Scholar